Symbol
Intellia Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$9.66
Current price of the stock
$2M
Trading volume of the stock
$975.7M
Market capitalization of the company
Small Cap
Category of market capitalization
39.10%
Long-term growth mean estimate
4.37
Mean analyst rating
314.91%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
6.73
Current ratio
100.00%
Gross profit margin
-1588.96%
Operating profit margin
-1588.96%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1489.54%
Pretax profit margin
-1489.54%
Net profit margin
-14.10%
Measures profitability relative to shareholders' equity
-14.10%
ROE excluding intangible assets
-11.57%
Measures profitability relative to total assets
-14.10%
Measures profitability relative to invested capital
0.01
Asset turnover ratio
-
Inventory turnover ratio
1.03
Receivables turnover ratio
87.46
Average number of days it takes to collect receivables
-1.78
Measures valuation relative to earnings
-2.27
P/E based on future earnings estimates
22.64
Measures valuation relative to sales
1.02
Measures valuation relative to book value
-0.96
Measures valuation relative to operating cash flow
-0.93
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
